Literature DB >> 8759610

Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994.

A C Moll1, S M Imhof, L M Bouter, D J Kuik, W Den Otter, P D Bezemer, J W Koten, K E Tan.   

Abstract

The aim of this register-based follow-up study was to evaluate the long-term cumulative incidence of second primary tumors (SPT) among survivors of hereditary retinoblastoma, with special interest for the incidence of pineoblastoma in retinoblastoma patients born after 1970. The Dutch Retinoblastoma Register was completed and updated: in the period 1945-1994, 639 retinoblastoma patients were registered. The vital status of each patient was obtained from the municipal registries and the Central Office of Genealogy. SPT were traced and histopathologically confirmed. Survival curves and cumulative incidence of SPT were calculated by the Kaplan-Meier method. The survival of patients with hereditary retinoblastoma was significantly shorter than that of patients with non-hereditary retinoblastoma. The cumulative incidence of SPT in hereditary patients was 3.7 and 17.7% at the ages of 10 and 35 years, respectively. Long-term follow-up revealed a high proportion of melanomas (7 melanomas out of 28 SPT). In the sub-cohort of the hereditary-retinoblastoma patient group born after 1970, the cumulative incidence of pineoblastomas at the age of 5 years was 9.3%. Our results suggest that patients with hereditary retinoblastoma should have careful follow-up, and procedures for diagnosing SPT and pineoblastomas at an early and potentially treatable stage should be developed.

Entities:  

Mesh:

Year:  1996        PMID: 8759610     DOI: 10.1002/(SICI)1097-0215(19960807)67:4<515::AID-IJC9>3.0.CO;2-V

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

2.  Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers.

Authors:  Victoria Sheen; Margaret A Tucker; David H Abramson; Johanna M Seddon; Ruth A Kleinerman
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

Review 3.  Determining the incidence of the hereditary form of retinoblastoma.

Authors:  Alan Edmund Stark
Journal:  Ann Transl Med       Date:  2016-05

4.  Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.

Authors:  Roshan V Sethi; Helen A Shih; Beow Y Yeap; Kent W Mouw; Robert Petersen; David Y Kim; John E Munzenrider; Eric Grabowski; Carlos Rodriguez-Galindo; Torunn I Yock; Nancy J Tarbell; Karen J Marcus; Shizuo Mukai; Shannon M MacDonald
Journal:  Cancer       Date:  2013-10-02       Impact factor: 6.860

5.  Germ-line and somatic DICER1 mutations in pineoblastoma.

Authors:  Leanne de Kock; Nelly Sabbaghian; Harriet Druker; Evan Weber; Nancy Hamel; Suzanne Miller; Catherine S Choong; Nicholas G Gottardo; Ursula R Kees; Surya P Rednam; Liselotte P van Hest; Marjolijn C Jongmans; Shalini Jhangiani; James R Lupski; Margaret Zacharin; Dorothée Bouron-Dal Soglio; Annie Huang; John R Priest; Arie Perry; Sabine Mueller; Steffen Albrecht; David Malkin; Richard G Grundy; William D Foulkes
Journal:  Acta Neuropathol       Date:  2014-07-15       Impact factor: 17.088

6.  Thermochemotherapy in hereditary retinoblastoma.

Authors:  A O Schueler; C Jurklies; H Heimann; R Wieland; W Havers; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

7.  Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862-1995.

Authors:  A C Moll; D J Kuik; L M Bouter; W Den Otter; P D Bezemer; J W Koten; S M Imhof; B P Kuyt; K E Tan
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

Review 8.  Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma.

Authors:  Uma M Sachdeva; Joan M O'Brien
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 9.  Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Authors:  Christine M Mueller; Neil Caporaso; Mark H Greene
Journal:  Urol Oncol       Date:  2008-06-18       Impact factor: 3.498

Review 10.  Radiation-sensitive genetically susceptible pediatric sub-populations.

Authors:  Ruth A Kleinerman
Journal:  Pediatr Radiol       Date:  2008-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.